The thyroid, parathyroid, and pineal glands

Physiological Basis of Aging and Geriatrics, Fourth Edition

Volumn , Issue , 2007, Pages 205-218

  Timiras, Paola S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84555215151     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (80)

1. Braverman LE, Utiger RD, eds.Werner and Ingbar’s the Thyroid. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000.
2. Scobbo RR. Thyroid status and survival in old age. JAMA 2005; 293(12): 1447-1448.
3. Habra M, Sarlis NJ. Thyroid and aging. Rev Endocr Metab Disord 2005; 6(2): 145-154.
4. Weissel M. Disturbances of thyroid function in the elderly. Wein Med Wochenschr 2006; 118(1-2): 16-20.
5. Robertson TB. The influence of thyroid alone and of thyroid administered together with nucleic acids upon the growth and longevity of the white mouse. Austral J Exp Biol Med Sci 1928; 5: 69-88.
6. Crew FAE. Rejuvenation of the aged fowl through thyroid medication. Proc Roy Soc Edinb 1925; 45: 252-260.
7. Ooka H, Fujita S, Yoshimoto E. Pituitary-thyroid activity and longevity in neonatally thyroxine-treated rats. Mech Ageing Dev 1983; 22(2): 113-120.
8. Ooka H, Shinkai T. Effects of chronic hyperthyroidism on the lifespan of the rat. Mech Ageing Dev 1986; 33(3): 275-282.
9. Fontana L, Klein S, Holloszy JO, et al. Effect of long-term calorie restriction with adequate protein and macronutrients on thyroid hormones. J Clin Endorincol Metab 2006; 91(8): 3232-3235.
10. Timiras PS. Hormones of the thyroid and parathyroid glands. In: Timiras PS, Quay WD, Vernadakis A, eds. Hormones and Aging. Boca Raton, FL: CRC Press, 1995: 85-105.
11. Lazarus JH. Thyroid disorders. In: Pathy MSJ, ed. Principles and Practice of Geriatric Medici. Vol. 2. 3rd ed. New York: John Wiley & Sons, 1998: 1307-1319.
12. Mariotti S, Barbesino G, Caturegli P, et al. Complex alteration of thyroid function in healthy centenarians. J Clin Endocrinol Metab 1993; 77: 1130-1134.
13. Anderson-Ranberg K, Jeune B, Hoier-Madsen M, et al. Thyroid function, morphology and prevalence of thyroid disease in a population-based study of Danish centenarians. J Am Geriatr Soc 1999; 47(10): 1238-1243.
14. Baranowska B, Wolinska-Witort E, Bik W, et al. Evaluation of neuroendocrine status in longevity. Neurobiol Aging 2007; 28(5): 774-783.
15. Rehman SU, Cope DW, Senseney AD, et al. Thyroid disorders in elderly patients. South Med J 2005; 98(5): 543-549.
16. Papini E, Gugliemi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002; 87: 1941-1946.
17. Hermus AR, Huysmans DA. Treatment of benign nodular thyroid disease. N Engl J Med 1998; 388(20): 1438-1447.
18. Hurley DL, Gharib H. Thyroid nodular disease: is it toxic or nontoxic, malignant or benign? Geriatrics 1995; 50(6): 24-26.
19. Kinder B. Surgical diseases of the thyroid and parathyroid glands. In: Rosenthal RA, Zenilman ME, Katlic MR, eds. Principles and Practice of Geriatric Surgery. New York: Springer, 2001: 281-300.
20. Trivalle C, Doucet J, Chassagne P, et al. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc 1996; 44(1): 50-53.
21. Mariotti S, Franceschi C, Cossarizza A, et al. The ageing thyroid. Endocrine Rev 1995; 16(6): 686-715.
22. Hintze G, Burghardt U, Baumert J, et al. Prevalence of thyroid dysfunction in elderly subjects from the general population in an iodine deficiency area. Aging (Milano) 1991; 3(4): 325-331.
23. Hershman JM, Pekary AE, Berg L, et al. Serum thyrotropin and thyroid hormone levels in elderly and middle-aged euthyroid persons. J Am Geriatr Soc 1993; 41(8): 823-828.
24. Szabolcs I, Ploenes C, Beyer M, et al. Factors affecting the serum free thyroxine levels in hospitalized chronic geriatric patients. J Am Geriatr Soc 1993; 41(7): 742-746.
25. Lindeman RD, Schade DS, LaRue A, et al. Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatr Soc 1999; 47(6): 703-709.
26. Everitt AV. The thyroid gland, metabolic rate and aging. In: Everitt AV, Burgess JA, eds. Hypothalamus, Pituitary and Aging. Springfield: Charles C. Thomas 1976: 498-510.
27. Choy VJ, Klemme WR, Timiras PS. Variant forms of immunoreactive thyrotropin in aged rats. Mech Ageing Dev 1982; 19(3): 273-278.
28. DeVito WJ. Neuroendocrine regulation of thyroid function. In: Conn PM, Freeman ME, eds. Neuroendocrinology in Physiology and Medicine. Totowa: Humana Press, 2000: 225-240.
29. Veldhuis JD. The neuroendocrine control of ultradian rhythms. In: Conn PM, Freeman ME, eds. Neuroendocrinology in Physiology and Medicine. Totowa: Humana Press, 2000: 453-474.
30. Murialdo G, Costelli P, Fonzi S, et al. Circadian secretion of melatonin and thyrotropin in hospitalized aged patients. Aging (Milano) 1993, 5(1): 39-46.
31. Mariotti S. The thyroid function and aging: do serum 3,5,3'- triiodothyronine and thyroid-stimulating hormone concentrations give the janus response? J Clin Endocrinol Metab 2005; 90(12): 6735-6738.
32. Peeters RP, van den Beld AW, Attalki H, et al. A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters. Am J Physiol Endocrinol Metab 2005; 289(1): E75-E81.
33. Brent GA. The molecular basis of thyroid hormone action. N Engl J Med 1994; 331(13): 847-853.
34. Katz D, Lazar MA. Dominant negative activity of an endogenous thyroid hormone receptor variant (a2) is due to competition for binding sites on target genes. J Biol Chem 1993; 268(28): 20904-20910.
35. Schueler PA, Schwartz HL, Strait KA, et al. Binding of 3,5,3'- triiodothyronine (T3) and its analogs to the in vitro translational products of c-erbA protooncogenes: differences in the affinity of the a- and b-forms for the acetic acid analog and failure of the human testis and kidney a-2 products to bind T3. Mol Endocrinol 1990; 4(2): 227-234.
36. Margarity M, Valcana T, Timiras PS. Thyroxine deiodination, cytoplasmic distribution, and nuclear binding of thyroxine and triiodothyronine in liver and brain of young rats. Mech Ageing Dev 1985; 29(2): 181-189.
37. Meunier N, Beattie JH, Ciarapica D, et al. Basal metabolic rate and thyroid hormones of late-middle-aged and older human subjects: the ZENITH study. Eur J Clin Nutr 2005; (suppl 2): S53-S57.
38. Chopra IJ. Triiodothyronines in Health and Disease, Monographs in Endocrinology. Vol. 18. New York: Springer-Verlag, 1981.
39. Utiger RD. The thyroid: Physiology, thyrotoxicosis, hypothyroidism, and the painful thyroid. In: Felig P, Baxter JD, Frohmar LA, eds. Endocrinology and Metabolism. 4th ed. New York: McGraw-Hill, 2001: 261-348.
40. Segall PE, Timiras PS. Age-related changes in thermoregulatory capacity of tryptophan-deficient rats. Fed Proc 1975; 34(1): 83-85.
41. Utiger RD. Altered thyroid function in nonthyroidal illness and surgery: totreat ornot to treat?NEngl JMed1995;333(23): 1562-1563.
42. Furmaniak J, Rees Smith B. The structure of thyroid autoantigens. Autoimmunity 1990; 7(1): 63-80.
43. Szabolcs I, Bernard W, Horster FA. Thyroid autoantibodies in hospitalized chronic geriatric patients: prevalence, effects of age, nonthyroidal clinical state, and thyroid function. J Am Geriatr Soc 1995; 43(6): 670-673.
44. Williams N. Thyroid disease: a case of cell suicide? Science 1997; 275(5302): 960-963.
45. Armengol MP, Juan M, Lucas-Martin A, et al. Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokinecontaining active intrathyroidal germinal centers. Am J Pathol 2001; 159(3): 861-873.
46. Franklyn JA. The management of hyperthyroidism. N Engl J Med 1994; 330(24): 1731-1738.
47. Toft AD. Thyroid hormone replacement-one hormone or two? N Engl J Med 1999; 340(6): 469-470.
48. Armbrecht HJ. Age-related changes in calcium homeostasis and bone loss. In: Pathy MSJ, ed. Principles and Practice of Geriatric Medici. Vol. 2. 3rd ed. New York: John Wiley & Sons, 1998: 1195-1202.
49. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000; 343(25): 1863-1875.
50. Blumenthal HT, Perlstein IB. The biopathology of aging of the endocrine system: the parathyroid glands. J Am Geriatr Soc 1993; 41(10): 1116-1129.
51. Endres DB, Morgan CH, Garry PJ, et al. Age-related changes in serum immunoreactive parathyroid hormone and its biological action in healthy men and women. J Clin Endocrinol Metab 1987; 65(4): 724-731.
52. Liang CT, Hanai H, Ishida M, et al. Regulation of renal sodium/calcium exchange by PTH: alteration with age. Environ Health Perspect 1990; 84: 137-140.
53. Fujita T. Calcium, parathyroids and aging. Contrib Nephrol 1991; 90: 206-211.
54. Peacock M. Interpretation of bone mass determinations as they relate to fracture: implications for asymptomatic primary hyperparathyroidism. J Bone Miner Res 1991; 6: S77-S82.
55. Silver J, Russell J, Sherwood LM. Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci USA 1985; 82(12): 4270-4273.
56. Flicker L, Lichtetnstein M, Colman P, et al. The effect of aging on intact PTH and bone density in women. J Am Geriatr Soc 1992; 40(11): 1135-1138.
57. Lindsay R, Nieves J, Formica C, et al. Randomized controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 1997; 350(9077): 550-555.
58. Mosekilde L, Danielsen CC, Sogaard CH, et al. The anabolic effects of parathyroid-hormone on cortical bone mass, dimensions and strength-assessed in a sexually mature, ovariectomized rat model. Bone 1995; 16(2): 223-230.
59. Lane NE, Sanchez S, Modin GW, et al. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. J Clin Invest 1998; 102(8): 1627-1633.
60. Dobnig H, Turner RT. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 1995; 136(8): 3632-3638.
61. Onyia JE, Bidwell J, Herring J, et al. In-vivo, human parathyroidhormone fragment (HPTH 1-34) transiently stimulates immediateearly response gene-expression, but not proliferation, in trabecular bone-cells of young-rats. Bone 1995; 17(5): 479-484.
62. Jilka RL, Weinstein RS, Bellido T, et al. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 1999; 104(4): 439-446.
63. Clissold SP, Fitton A, Chrisp P. Intranasal salmon calcitonin. A review of its pharmacological properties and potential utility in metabolic bone disorders associated with aging. Drugs Aging 1991; 1(5): 405-423.
64. Rakopoulus M, Ikegame M, Findlay DM, et al. Short treatment of osteoclasts in bone-marrow culture with calcitonin causes prolonged suppression of calcitonin receptor messenger-RNA. Bone 1995; 17(5): 447-453.
65. Wada S, Udagawa N, Nagata N, et al. Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase alpha-mediated mechanism. Endocrinology 1996; 137(1): 312-320.
66. Yu HS, Reiter RJ, eds. Melatonin: Biosynthesis, Physiological Effects, and Clinical Applications. Boca Raton: CRC Press, 1993.
67. Quay WB, Kachi T. Amine secreting endocrines In: Timiras PS, Quay WD, Vernadakis A, eds. Boca Raton: CRC Press, 1995: 67-84.
68. Urbanski HF. Influence of light and the pineal gland on biological rhythms. In: Conn PM, Freeman ME, eds. Neuroendocrinology in Physiology and Medicine. Totowa: Humana Press, 2000: 405-420.
69. Wayne NL. Neuroendocrine regulation of biological rhythms. In: Conn PM, Freeman ME, eds. Neuroendocrinology in Physiology and Medicine. Totowa: Humana Press, 2000: 421-434.
70. Malpaux B. The neuroendocrine control of circadian rhythm. In: Conn PM, Freeman ME, eds. Neuroendocrinology in Physiology and Medicine. Totowa: Humana Press, 2000: 435-454.
71. Refinetti R. Circadian Physiology. 2nd ed. Boca Raton, FL: CRC Press/Taylor & Francis Group, 2006.
72. Kachi T, Tanaka D, Watanabe S, et al. Physiological pineal effects on female reproductive function of laboratory rats: prenatal development of pups, litter size and estrous cycle in middle age. Chronobiol Int 2006; 23(1-2): 289-300.
73. Reuss S, Spies C, Schroder H, et al. The aged pineal gland: reduction in pinealocyte number and adrenergic innervation in male rats. Exp Gerontol 1990; 25(2): 183-188.
74. Brzezinski A. Melatonin in humans. N Engl J Med 1997; 336(3): 186-195.
75. Dawson D, Encel N. Melatonin and sleep in humans. J Pineal Res 1993; 15(1): 1-12.
76. Garfinkel D, Laudon M, Nof D, et al. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995; 346(8974): 541-544.
77. Haimov I, Lavie P, Laudon M, et al. Melatonin replacement therapy of elderly insomniacs. Sleep 1995; 18(7): 598-603.
78. Reiter RJ, Tan DX, Poeggeler B, et al. Melatonin as a free radical scavenger: implications for aging and age-related diseases. Ann NY Acad Sci 1994; 719: 1-12.
79. Reiter RJ. The role of the neurohormone melatonin as a buffer against macromolecular oxidative damage. Neurochem Int 1995; 27(6): 453-460.
80. Srinivasan V. Melatonin, oxidative stress and ageing. Current Science 1999; 76: 46-54.